Increased Plasma Magnesium Concentrations 3 Years After Biliopancreatic Diversion with Duodenal Switch
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Biliopancreatic diversion with duodenal switch, BPD-DS, is a surgical procedure for treatment of super obese patients. It renders very good weight results and it strongly reduces the incidence of type 2 diabetes. One important mechanism of weight reduction after BPD-DS is malabsorption. Hypomagnesemia is an established cardiovascular risk factor. While it is well-known that magnesium levels decline after jejuno-ileal bypass and increase after gastric bypass surgery, information on how magnesium status is affected by BPD-DS is scant. The aim of the present study was to evaluate plasma magnesium concentrations (P-Mg) after BPD-DS.
Thirty-one patients, all Caucasians (9 diabetics, 12 men, age 38 ± 8 years, weight 159 ± 22 kg, body mass index (BMI) 53.9 ± 5.2 kg/m2) underwent BPD-DS. We evaluated weight, glycated hemoglobin levels (HbA1c) and P-Mg preoperatively as well as at 1 and 3 years after surgery. All subjects were treated with vitamin and mineral substitution after surgery, including 100 mg of magnesium salt. P-Mg was analyzed with respect to changes over time, correlation to BMI and HbA1c levels before and 3 years after surgery.
The plasma magnesium concentrations increased by 15 % from 0.77 ± 0.07 to 0.88 ± 0.09 mmol/l over 3 years (p < 0.001). The weight loss was 71 ± 25 kg. No patient had diabetes at follow-up. No correlations between P-Mg and BMI or HbA1c were seen.
Although exerting much of its weight-reducing effect by a malabsorptive mechanism, BPD-DS yields a rise in P-Mg 3 years postoperatively, possibly contributing to the improved metabolic state after this operation.
- Deitel M. The obesity epidemic. Obes Surg. 2006;16(4):377–8. CrossRef
- Ford ES, Mokdad AH. Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S1–8. CrossRef
- Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich). 2009;11(12):761–5. CrossRef
- Mathieu P, Poirier P, Pibarot P, et al. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension. 2009;53(4):577–84. CrossRef
- Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9. CrossRef
- Oguma Y, Sesso HD, Paffenbarger Jr RS, et al. Weight change and risk of developing type 2 diabetes. Obes Res. 2005;13(5):945–51. CrossRef
- Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005;9(3):211–24. CrossRef
- Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753–61. CrossRef
- Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. CrossRef
- Colquitt J, Clegg A, Loveman E, et al. Surgery for morbid obesity. Cochrane Database Syst Rev 2005 (4):CD003641.
- Altura BM, Seelig MD. Distribution of Mg+ and its vital role in life processes. In: Altura BD, Seeling MJ, editors. Magnesium in cellular processes and medicine. Basel: Krager; 1987. p. 1–4.
- Lima Mde L, Cruz T, Rodrigues LE, et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome—evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009;83(2):257–62. CrossRef
- Huerta MG, Roemmich JN, Kington ML, et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175–81. CrossRef
- Haglin L, Tornkvist B, Backman L. Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium. Acta Diabetol. 2007;44(3):138–43. CrossRef
- Chiuve SE, Korngold EC, Januzzi Jr JL, et al. Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr. 2011;93(2):253–60. CrossRef
- Khan AM, Sullivan L, McCabe E, et al. Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease. Am Heart J. 2010;160(4):715–20. CrossRef
- Deitel M, Shahi B, Anand PK, et al. Long-term outcome in a series of jejunoileal bypass patients. Obes Surg. 1993;3(3):247–52. CrossRef
- Vage V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients. Obes Surg. 2002;12(3):312–8. CrossRef
- Rasmussen I, Enblad P, Arosenius KE. Jejunoileal bypass for morbid obesity. Report of a series with long-term results. Acta Chir Scand. 1989;155(8):401–7.
- Van Gaal L, Delvigne C, Vandewoude M, et al. Evaluation of magnesium before and after jejuno-ileal versus gastric bypass surgery for morbid obesity. J Am Coll Nutr. 1987;6(5):397–400.
- Johansson HE, Zethelius B, Ohrvall M, et al. Serum magnesium status after gastric bypass surgery in obesity. Obes Surg. 2009;19(9):1250–5. CrossRef
- Johansson HE, Haenni A, Zethelius B. Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery. J Obes. 2011;2011:273105.
- Skroubis G, Anesidis S, Kehagias I, et al. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg. 2006;16(4):488–95. CrossRef
- Rustad P, Felding P, Franzson L, et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand J Clin Lab Invest. 2004;64(4):271–84. CrossRef
- Lee S, Park HK, Son SP, et al. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis. 2009;19(11):781–8. CrossRef
- Diniz Mde F, Diniz MT, Sanches SR, et al. Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg. 2004;14(9):1222–6. CrossRef
- Goode LR, Brolin RE, Chowdhury HA, et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res. 2004;12(1):40–7. CrossRef
- Yajnik CS, Smith RF, Hockaday TD, et al. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed). 1984;288(6423):1032–4. CrossRef
- Lind L, Hanni A, Lithell H, et al. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens. 1995;8(9):894–901. CrossRef
- McNair P, Christensen MS, Christiansen C, et al. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest. 1982;12(1):81–5. CrossRef
- Djurhuus MS, Skott P, Vaag A, et al. Hyperglycaemia enhances renal magnesium excretion in type 1 diabetic patients. Scand J Clin Lab Invest. 2000;60(5):403–9. CrossRef
- Resnick LM, Gupta RK, Bhargava KK, et al. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17(6 Pt 2):951–7. CrossRef
- Lecube A, Baena-Fustegueras JA, Fort JM, et al. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLoS One. 2012;7(1):e30599. CrossRef
- Hedberg J, Sundbom M. Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis. 2012;8(3):338–43. CrossRef
- Bendezu R, Wieland RG, Green SG, et al. Certain metabolic consequences of jejunoileal bypass. Am J Clin Nutr. 1976;29(4):366–70.
- Ahmad U, Danowski TS, Nolan S, et al. Remissions of diabetes mellitus after weight reduction by jejunoileal bypass. Diabetes Care. 1978;1(3):158–65. CrossRef
- Ismail Y, Ismail AA, Ismail AA. The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med. 2010;48(3):323–7. CrossRef
- de Valk HW, Verkaaik R, van Rijn HJ, et al. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med. 1998;15(6):503–7. CrossRef
- Eibl NL, Kopp HP, Nowak HR, et al. Hypomagnesemia in type II diabetes: effect of a 3-month replacement therapy. Diabetes Care. 1995;18(2):188–92. CrossRef
- Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55(6):1161–7.
- Reffelmann T, Dorr M, Ittermann T, et al. Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors. Atherosclerosis. 2010;213(2):563–9. CrossRef
- Reffelmann T, Ittermann T, Dorr M, et al. Low serum magnesium concentrations predict cardiovascular and all-cause mortality. Atherosclerosis. 2011;219(1):280–4. CrossRef
- Peacock JM, Ohira T, Post W, et al. Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010;160(3):464–70. CrossRef
- Increased Plasma Magnesium Concentrations 3 Years After Biliopancreatic Diversion with Duodenal Switch
Volume 22, Issue 11 , pp 1708-1713
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Biliopancreatic diversion
- Bariatric surgery
- Industry Sectors